|
|||||
|
|
The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function |
|
| Authors: | G. Everson,K. C. Lasseter,K. E. Anderson,L. A. Bauer,R. L. Carithens Jr, K. D. Wilner,A. Johnson,R. J. Anziano,T. A. Smolarek,& R. Z. Turncliff |
| Affiliation: | University of Colorado, Health Sciences Center, Denver, CO, USA,;Clinical Pharmacology Associates, Miami, FL, USA,;University of Texas Medical Branch, Galveston, TX, USA,;University of Washington Departments of Pharmacy and Laboratory Medicine, Seattle, WA, USA, and;Departments of Clinical Research and Drug Metabolism, Pfizer Central Research, Groton, CT 06340, USA |
| Abstract: | |
| Keywords: | ziprasidone pharmacokinetics hepatic impairment metabolism |